Mineralys Therapeutics, Inc. (MLYS) Earnings
|
Expand Research on MLYS
| Next EPS Date | 11/16/26 | EPS Growth Rate | -44.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +34.2% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/16/26  |
Q326 | N/A | -$0.75 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/26 |
Q226 | -$2.85 | -$2.63 | -$0.22 | N/A | N/A | N/A |  | | Details | |
| 5/6/26 | Q126 | -$0.47 | -$0.81 | +$0.34 | N/A | N/A | N/A | | | Details | |
| 3/12/26 | Q425 | -$0.40 | -$0.94 | +$0.54 | N/A | N/A | N/A | | | Details | |
| 11/10/25 |
Q425 | N/A | -$0.96 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/10/25 | Q325 | -$0.52 | -$0.96 | +$0.44 | N/A | N/A | N/A | | | Details | |
| 8/12/25 | Q225 | -$0.66 | -$1.06 | +$0.40 | N/A | N/A | N/A | | | Details | |
| 5/12/25 | Q125 | -$0.79 | -$1.08 | +$0.29 | N/A | N/A | N/A | | | Details |
